The 16th European Glaucoma Society Congress convenes in Dublin

News
Article

This year’s meeting will take place in Ireland’s technology and business hub

A view of the Convention Centre Dublin from the River Liffey. Image credit: ©Alexander – stock.adobe.com

The venue is located in Dublin’s Docklands, a neighborhood noted for its connections to technology companies and finance firms. Image credit: ©Alexander – stock.adobe.com

From 1 June to 4 June, the European Glaucoma Society (EGS) will convene in Dublin, Ireland, for the 16th EGS Congress. The four-day meeting will include lectures, panels and demonstrations on a number of surgical, practice-centric and patient-focused topics. The first day of programming will include a keynote lecture titled “Interpreting surgical innovations,” presented by Professor Roger Kneebone, MD, PhD.

Hands-on surgical symposia, taking place each day, will focus on bleb forming devices, trabeculectomy, tubes and MIGS. Posters at the meeting are divided into a wide range of categories: diagnosis, surgical, laser and medical treatments, follow up and glaucoma progression, genetic research,pathogenesis, epidemiology, quality of life, health economics and visual disability. A Technical Exhibition will feature industry partners showcasing new products and devices.

In a welcome letter, the EGS leadership and programme planning committee announced1 the popular EGS Surgery Day would return for 2024, putting a focus on challenges related to novel and innovative surgical techniques. The letter also highlighted recent efforts which would be spotlighted at the congress. Over the last few years, leadership wrote, the society has intensively worked on “the Real World Data Project, the Surgery Project, the EGS Glaucoma Fellowship Project, the Research Priorities Project, the Patients Initiative and the Outcomes Project.” Innovations and updates from those ongoing projects will be incorporated into the meeting’s scientific programme. These core concepts “[are] building the scaffold for a high quality scientific exchange from the first day until the very last session in an open-minded, multicultural environment,” the letter read.

The venue for this year’s meeting is The Convention Centre Dublin (The CCD), located in Dublin’s Docklands, a neighborhood noted for its connections to technology companies and finance firms.

General information about the Congress can be found at this link. The full scientific programme, including abstract book and the programme-at-a-glance, can be found at this link.

Reference

  1. European Glaucoma Society Executives. Welcome letter. European Glaucoma Society. Published May 2024. Accessed May 2024. https://egscongress.org/welcome/
Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.